SPOTLIGHT -
Buprenorphine and Its Therapeutic Potential in Psychiatric Disorders
Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Neurological and Neuropsychiatric Complications of COVID-19
An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.
Cults in the Age of Influence
Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.
Leading the Artificial Intelligence Revolution
Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.
Assessing Gaps and Opportunities in ECT, rTMS, and DBS Guidelines
The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.
Clearing the ‘Brain Fog’ in Long COVID
Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.
The Benefits of Being in Person at the 2022 APA Annual Meeting
Our Editor in Chief is thrilled to be live and in person at the 2022 APA Annual Meeting in New Orleans. Here's why.
Embracing Humanity at the 2022 APA Annual Meeting
"When we embrace humanity, everyone wins."
The Importance of Psychosocial Stress Explored at the 2022 APA Annual Meeting
How do social stressors contribute to patient symptoms?
More Than a Knockout: Structural Brain Effects in MMA Sparring
What are the neuropsychiatric effects of sparring in mixed martial arts? New research presented at the 2022 APA Annual Meeting elucidates the issues.
Topic Highlights from the 2022 APA Annual Meeting With Helen Lavretsky, MD, MS
What are the Psychiatric Times™ Editorial Board Members talking about at the 2022 APA Annual Meeting in New Orleans?
New Data Shows Trauma’s Ripple Effects
Research explored how a traumatic explosion affected individuals around the world.
Pharmacogenetics: Clinical Applications and Cases Across the Lifespan
What are the current dosing guidelines for the implementation of pharmacogenetics into practice?
Understanding the Neurobiology of PTSD
How can we more effectively help patients with PTSD? Charles B. Nemeroff discusses the diagnosis, epidemiology, and pathophysiology of PTSD, along with current and emerging treatments, at the 2022 APA Annual Meeting.
Combating Cult Mind Control
How can we help individuals who are under undue influence or authoritative control?
Major Diagnostic Differences Between DSM-5 and ICD-11
Do classification systems make a difference? A presentation at the 2022 APA Annual Meeting noted 4 key diagnoses that differ significantly in the classification systems.
New Weapon in the Fight Against Opioid Use Disorders
New research presented at the 2022 American Psychiatric Association Annual Meeting evaluated program to help address the opioid epidemic.
Exploring the Social Determinants of Mental Health
A look at the theme for the 2022 American Psychiatric Association Annual Meeting.
Big Data for Psychosis Prediction
The Accelerating Medicines Partnership in Schizophrenia aims to develop better treatments for the early stages of psychotic illness.
Chester M. Pierce Human Rights Award Winner to Give Inaugural Award Lecture at 2022 APA Annual Meeting
This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.
Climate Psychiatry 101
What is the clinical impact of climate psychiatry?
Current Trends in Suicide: APA Preview With the Chief Medical Officer of the AFSP
Christine Yu Moutier, MD, is excited to see you at the APA Annual Meeting in New Orleans!
Must Sees in New Orleans: Things to Check Out During 2022 APA
If you're attending APA 2022 in New Orleans, here are some other things to check out in the city.
A Disruption Warning From the APA Meeting—And All That Jazz
Are you attending the APA Annual Meeting in New Orleans? Here's a preview of one doctor's talk on jazz and racism.
Catch Us at Booth 1852
Are you attending APA’s 2022 Annual Meeting in New Orleans? Don’t miss us!
The APA Council on Children, Adolescents, and Their Families Shares Important Information on Cyberbullying
As the nation continues to grapple with the children’s mental health crisis, the American Psychiatric Association Council on Children, Adolescents, and Their Families is exploring the ways in which clinicians can best support their patients.
Dreaming of New Treatments
Sleep problems are understudied, underdiagnosed, and undertreated.
Amidst Multiple Crises, NIMH Pursues Research to Improve Outcomes
Joshua A. Gordon, MD, PhD, National Institute of Mental Health Director, leverages lessons from past natural disasters and traumas to foster resiliency and inform future research endeavors.
Fauci Addresses Attendees at APA Annual Meeting
In his William C. Menninger Memorial Lecture, Anthony S. Fauci, MD, shared lessons learned and remaining challenges for the COVID-19 pandemic, especially in terms of mental health and behavioral issues.
Agree to Disagree: Excited Delirium Syndrome as Volatile as the Term Itself
What is excited delirium syndrome and how should it be treated? The short answer is we do not know.